Engineered AAV Capsids for Cross-Species Liver Cell Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Developing adeno-associated viral vectors (AAV) that simultaneously exhibit high production yield and efficiently target specific cell types across species for disease treatment is challenging, as existing methods struggle to optimize capsids for multiple traits concurrently.
Innovation Solution
Engineering AAV capsids with specific amino acid sequences, such as AAV-BI151 to AAV-BI157, which demonstrate at least 85% amino acid sequence identity, to enhance tropism and production yield, allowing targeted delivery to liver cells across species.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If random library selection methods are used to develop AAV capsids with novel tropisms, then some enhanced tropism variants can be identified, but the process requires many years and significant resources and fails to optimize multiple traits simultaneously
Solution Approach 1:
The patent applies parameter changes by systematically modifying specific amino acid positions in the AAV capsid sequence based on predicted binding interfaces, rather than relying on random mutations. This directed approach to changing sequence parameters enables simultaneous optimization of multiple traits including tropism, production yield, and stability within a shorter development timeframe.
Solution Approach 2:
The patent creates capsid variants that achieve multiple functions simultaneously - enhanced tissue tropism, improved production yield, and maintained stability - through coordinated modifications at predicted binding interfaces. This multi-functional optimization resolves the contradiction by designing capsids that satisfy multiple requirements in parallel rather than sequentially.
2Reliability
If AAV capsids are optimized for one trait such as tropism, then enhanced targeting efficiency is achieved, but optimization for other traits like production yield becomes difficult
Solution Approach 1:
The patent applies local quality by making targeted amino acid modifications specifically at predicted protein-protein binding interfaces on the capsid surface. Rather than uniform random mutations throughout the sequence, this localized approach to quality enhancement at critical interfaces enables simultaneous improvement of multiple traits including targeting efficiency and production yield without compromising overall capsid function.
3Reliability
If extensive sampling of protein sequence space is performed to find rare variants enhanced across multiple traits, then potentially superior capsids can be identified, but the vast sequence space makes effective sampling by chance impractical
Solution Approach 1:
The patent applies preliminary action by using computational prediction to identify favorable amino acid positions at binding interfaces before conducting experimental validation. This preliminary computational screening narrows the vast sequence space to a focused set of predicted optimal variants, enabling efficient exploration of sequence space and identification of rare multi-trait enhanced capsids without requiring exhaustive random sampling.
Data Source
AI summary
The invention provides adeno-associated viral vectors and methods of using such vectors for cell transduction.